Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionComerica Bank
Latest Disclosed Ownership23,996 shares
Latest Disclosed Value $ 516,394
Comerica Bank reports 3.07% decrease in ownership of SRPT / Sarepta Therapeutics, Inc.

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 23,996 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $516,394 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 24,757 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -3.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 23,996 -761 -3.07 516 8.18 0.0021
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 24,757 -2,818 -10.22 477 1.27 0.0018
2025-08-14 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 27,575 257 0.94 472 -72.98 0.0018
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 27,318 -1,146 -4.03 1,743 -49.62 0.0073
2025-02-14 2024-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 28,464 -1,712 -5.67 3,461 -8.17 0.0140
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 28,464 -1,712 3,461 0.0116
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 30,176 -4,031 -11.78 3,769 -30.27 0.0149
2024-08-15 2024-06-30 13F SAREPTA THERAPEUTICS COMMON 803607100 34,207 30,871 925.39 5,405 1,153.83 0.0225
2024-05-16 2024-03-31 13F SAREPTA THERAPEUTICS COMMON 803607100 3,336 2,770 489.40 432 698.15 0.0019
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COMMON 803607100 566 -102,701 -99.45 55 -99.57 0.0003
2023-11-21 2023-09-30 13F SAREPTA THERAPEUTICS COMMON 803607100 103,267 103,267 12,518 0.0652
2023-08-22 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -82,228 -100.00 0 -100.00
2023-01-26 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 82,228 37,502 83.85 11 -99.80 0.0831
2022-10-28 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 44,726 44,726 4,947 0.0417
2021-04-28 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -29,270 -100.00 0 -100.00
2021-01-28 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 29,270 9,422 47.47 2,875 5.16 0.0182
2020-10-30 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 19,848 -265 -1.32 2,734 -17.38 0.0198
2020-07-31 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 20,113 -3,618 -15.25 3,309 14.74 0.0255
2020-05-01 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 23,731 -890 -3.61 2,884 -0.59 0.0265
2020-02-07 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 24,621 -1,350 -5.20 2,901 33.75 0.0220
2019-10-31 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 25,971 2,044 8.54 2,169 -41.14 0.0171
2019-08-02 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 23,927 -431 -1.77 3,685 19.49 0.0295
2019-05-02 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 24,358 -575 -2.31 3,084 6.82 0.0250
2019-02-06 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 24,933 5,173 26.18 2,887 8.78 0.0245
2018-11-01 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 19,760 3,386 20.68 2,654 18.06 0.0214
2018-08-01 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 16,374 172 1.06 2,248 76.59 0.0157
2018-05-01 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 16,202 -673 -3.99 1,273 14.68 0.0091
2018-02-02 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 16,875 16,875 1,110 0.0074
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.